Inactive Instrument
CUSPIS CAP L Stock Toronto S.E.
Stocks
CUSP.P
CA23168X1078
Specialty Chemicals
OTC Markets Traded| Market Cap | 313M 218M 191M 176M 162M 308M 20.75B 2.1B 824M 10.23B 817M 799M 35.2B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 313M 218M 191M 176M 162M 308M 20.75B 2.1B 824M 10.23B 817M 799M 35.2B | EV / Sales 2026 * |
112x | EV / Sales 2027 * | 4.29x |
| Free-Float |
86.06% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +14.14% |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Nicol
CEO | Chief Executive Officer | 51 | 2016-08-09 |
Joshua George
DFI | Director of Finance/CFO | - | 2024-04-07 |
Stuart Watson
PRN | Corporate Officer/Principal | - | 2026-04-21 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Nicol
BRD | Director/Board Member | 51 | 2016-08-09 |
Robert Galyen
BRD | Director/Board Member | - | 2023-06-30 |
Jack Perkowski
CHM | Chairman | 76 | 2023-10-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +14.14% | +41.25% | - | - | 217M | ||
| +4.37% | -8.78% | +148.35% | +36.64% | 6.3B | ||
| +1.31% | -3.44% | -30.05% | -47.93% | 2.31B | ||
| -7.19% | -3.76% | +132.08% | +197.00% | 1.17B | ||
| -2.91% | -16.24% | +53.41% | +144.90% | 1.16B | ||
| +1.17% | -1.87% | +18.23% | +1.24% | 565M | ||
| +0.66% | +3.06% | -27.74% | -53.24% | 535M | ||
| +2.12% | -6.56% | -18.56% | -10.12% | 281M | ||
| +2.39% | -5.61% | -45.80% | +10.05% | 230M | ||
| -1.99% | -9.20% | -36.48% | -55.42% | 193M | ||
| Average | +1.41% | -4.29% | +21.49% | +24.79% | 1.42B | |
| Weighted average by Cap. | +1.82% | -2.61% | +82.74% | +37.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.8M 1.95M 1.71M 1.57M 1.45M 2.75M 186M 18.79M 7.37M 91.49M 7.31M 7.15M 315M | 73M 50.74M 44.46M 40.98M 37.84M 71.77M 4.84B 490M 192M 2.39B 190M 186M 8.21B |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Specialty Chemicals
















